National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

palladium Pd 103
A radioisotope of the metal palladium used in brachytherapy implants or 'seed'. With a half-life of 17 days, palladium 103 administered with brachytherapy allows continuous, tumor-site specific low-energy irradiation to the tumor cell population while sparing normal adjacent tissues from radiotoxicity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Palladium 103
Abbreviation:Pd 103



Previous:PADRE-CMV fusion peptide vaccine, Palestrol, palifermin, palifosfamide, Pallace
Next:palladium-bacteriopheophorbide, palonosetron hydrochloride, pamidronate disodium, pan HER/VEGFR2 receptor tyrosine kinase inhibitor BMS-690154, pan-AKT kinase inhibitor GSK690693

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov